pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

23,715 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area

    no tagged catalysts yet

    Week of Feb 16, 2026

    50
    ›Feb 16, 2026grant195d agoJOHNS HOPKINS UNIVERSITY — Social Context, Community Norms, and Adolescent Girls' Sexual Health and Well...Johns Hopkins University

    HD grant. $49,538. PI: Charlotte Greenbaum

    full page →nih reporter ↗
    ›Feb 16, 2026grant195d agoUT SOUTHWESTERN MEDICAL CENTER — Tachycardia-induced Metabolic Remodeling Drives Cardiac Dysfunction

    HL grant. $249,000. PI: Chengyi Tu

    full page →nih reporter ↗
    ›Feb 16, 2026grant195d agoPENNSYLVANIA STATE UNIVERSITY, THE — Evolutionary and drug resistance landscape of human tyrosine kinases

    HG grant. $806,828. PI: David Martin McCandlish

    full page →nih reporter ↗
    ›Feb 16, 2026grant195d agoOKLAHOMA STATE UNIVERSITY STILLWATER — Manipulating interferon levels toward a safe and effective live single-cycle ...

    AI grant. $403,320. PI: Antonius G Oomens

    full page →nih reporter ↗
    ›Feb 17, 2026approval194d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval194d agoGABAPENTIN — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval194d agoIDELALISIB — FDA approvalIDELALISIB

    Sponsor: NATCO. Form: TABLET. Route: ORAL

    full page →IDELALISIB →fda approvals ↗
    ›Feb 17, 2026approval194d agoAMBRISENTAN — FDA approvalAMBRISENTAN

    Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

    full page →AMBRISENTAN →fda approvals ↗
    ›Feb 17, 2026approval194d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval194d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval194d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval194d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval194d agoSODIUM PHENYLBUTYRATE — FDA approvalSODIUM PHENYLBUTYRATE

    Sponsor: NAVINTA LLC. Form: TABLET. Route: ORAL

    full page →SODIUM PHENYLBUTYRATE →fda approvals ↗
    ›Feb 17, 2026approval194d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

    Sponsor: TAGI. Form: INJECTABLE. Route: INJECTION

    full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗
    ›Feb 17, 2026approval194d agoCOLCHICINE — FDA approvalCOLCHICINE

    Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL

    full page →COLCHICINE →fda approvals ↗
    ›Feb 17, 2026approval194d agoAMBRISENTAN — FDA approvalAMBRISENTAN

    Sponsor: SIGMAPHARM LABS LLC. Form: TABLET. Route: ORAL

    full page →AMBRISENTAN →fda approvals ↗
    ›Feb 17, 2026approval194d agoMEDICAL AIR, USP — FDA approval

    Sponsor: INDUSTRIAL WELDING SUPPLY CO OF HARVEY INC. Form: GAS. Route: INHALATION

    full page →fda approvals ↗
    ›Feb 17, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval194d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval194d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗
    ›Feb 17, 2026approval194d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Feb 17, 2026approval194d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Feb 17, 2026approval194d agoRELGAABI (GABAPENTIN) — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval194d agoANAGRELIDE HYDROCHLORIDE — FDA approvalTakeda Pharmaceuticals USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval194d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

    Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval194d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: QILU. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Feb 17, 2026grant194d agoCHILDREN'S HOSP OF PHILADELPHIA — Role of the PilC1 and PilC2 pilus-associated proteins in Kingella kingae path...PATH

    AI grant. $853,112. PI: Joseph W. St. Geme

    full page →nih reporter ↗
    ›Feb 17, 2026grant194d agoWASHINGTON STATE UNIVERSITY — Role of Fn-14 receptor in TNF-induced inflammation and tissue destruction

    AI grant. $497,779. PI: Salah-uddin Ahmed

    full page →nih reporter ↗
    ›Feb 17, 2026grant194d agoUNIVERSITY OF TEXAS DALLAS — Disruption of a DNA Repair Protein Promotes Antibiotic Resistance in Acinetob...

    AI grant. $434,625. PI: Nicholas A Dillon

    full page →nih reporter ↗
    ›Feb 17, 2026grant194d agoUNIVERSITY OF PENNSYLVANIA — The 22nd International Vasculitis WorkshopUniversity of Pennsylvania

    TR grant. $18,000. PI: Peter A Merkel

    full page →nih reporter ↗
    ›Feb 17, 2026grant194d agoUNIVERSITY OF CALIFORNIA-IRVINE — Vancomycin-Teixobactin Conjugates

    AI grant. $404,866. PI: JAMES S NOWICK

    full page →nih reporter ↗
    ›Feb 17, 2026grant194d agoDUKE UNIVERSITY — Identifying Endocrine-Disrupting Plastic Additives using Machine LearningDuke University

    ES grant. $444,125. PI: Daniel Reker

    full page →nih reporter ↗
    ›Feb 17, 2026grant194d agoJOHNS HOPKINS UNIVERSITY — Modification of the predisposition for ectopic calcificationJohns Hopkins University

    OD grant. $388,750. PI: Shira G Ziegler

    full page →nih reporter ↗
    ›Feb 17, 2026grant194d agoDUKE UNIVERSITY — Understanding environmental mitochondrial healthDuke University

    ES grant. $1,006,211. PI: Joel Newman Meyer

    full page →nih reporter ↗
    ›Feb 17, 2026grant194d agoJOHNS HOPKINS UNIVERSITY — Generating Critical Knowledge on the NMP Peptide Signaling in the Peripheral ...Johns Hopkins University

    NS grant. $232,938. PI: SETH S MARGOLIS

    full page →nih reporter ↗
    ›Feb 18, 2026approval193d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Feb 18, 2026approval193d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Feb 18, 2026approval193d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Feb 18, 2026approval193d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Feb 18, 2026approval193d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Feb 18, 2026approval193d agoARBLI (LOSARTAN POTASSIUM) — FDA approvalLOSARTAN POTASSIUM

    Sponsor: SCIENTURE. Form: SUSPENSION. Route: ORAL

    full page →LOSARTAN POTASSIUM →fda approvals ↗
    ›Feb 18, 2026approval193d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalEzra Ventures LLC

    Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 18, 2026approval193d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalEzra Ventures LLC

    Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 18, 2026approval193d agoARIPIPRAZOLE — FDA approvalaripiprazole LA

    Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →aripiprazole LA →fda approvals ↗
    ← prev
    page 432 of 475
    next →
    $SCNX0.3314-4.08%